Related Experiment Video
Updated: May 21, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases
1Department of Dermatology, St George Hospital, Sydney, NSW, Australia.
Autoimmune bullous diseases describes a heterogenous group of diseases with skin and mucosal involvement with varying degrees of mortality. Intravenous immunoglobulin (IVIg) is a specialised treatment used in the management of these AIBD with variable success. This paper outlines the use of IVIg in these diseases.
Autoimmune bullous diseases describes a heterogenous group of diseases with skin and mucosal involvement with varying degrees of mortality. Intravenous immunoglobulin (IVIg) is a specialised treatment used in the management of these AIBD with variable success. This paper outlines the use of IVIg in these diseases.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Tumor Immunotherapy
Inflammatory Bowel Disease IV: Clinical Manifestations

